FUBON ASSET MANAGEMENT CO LTD NYSE FACTSHEET GLOBAL GENOMICS & IMMUNOFUBON ASSET MANAGEMENT CO LTD NYSE FACTSHEET GLOBAL GENOMICS & IMMUNOFUBON ASSET MANAGEMENT CO LTD NYSE FACTSHEET GLOBAL GENOMICS & IMMUNO

FUBON ASSET MANAGEMENT CO LTD NYSE FACTSHEET GLOBAL GENOMICS & IMMUNO

No trades
See on Supercharts

Key stats


Assets under management (AUM)
‪1.65 B‬TWD
Fund flows (1Y)
‪−663.07 M‬TWD
Dividend yield (indicated)
Discount/Premium to NAV
−0.5%

About FUBON ASSET MANAGEMENT CO LTD NYSE FACTSHEET GLOBAL GENOMICS & IMMUNO


Issuer
Fubon Financial Holding Co., Ltd.
Brand
Fubon
Expense ratio
1.05%
Inception date
Oct 4, 2021
Index tracked
NYSE FactSet Global Genomics and Immuno Biopharma Index
Management style
Passive
ISIN
TW0000089705
Fubon NYSE FactSet Global Genomics and Immuno Biopharma Exchange Traded Fund seeks investment results that closely track the performance of NYSE FactSet Global Genomics and Immuno Biopharma Index, before fees and expenses

Classification


Asset Class
Equity
Category
Sector
Focus
Theme
Niche
Genomic advancements
Strategy
Vanilla
Weighting scheme
Market cap
Selection criteria
Market cap

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance
NAV total return

What's in the fund


As of December 24, 2024
Exposure type
StocksBonds, Cash & Other
Health Technology
Stocks98.62%
Health Technology97.61%
Commercial Services0.49%
Health Services0.49%
Bonds, Cash & Other1.38%
Futures1.41%
Cash−0.03%
Stock breakdown by region
69%21%9%
North America69.35%
Europe21.36%
Asia9.29%
Latin America0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows